Quanterix Corporation Depreciation
Quanterix Corporation (QTRX) reported Depreciation of $7.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-02
- Quanterix Corporation depreciation for fiscal 2025 was $7.00M, a 45.83% increase from fiscal 2024.
- Quanterix Corporation depreciation for fiscal 2024 was $4.80M, a 2.13% increase from fiscal 2023.
- Quanterix Corporation depreciation for fiscal 2023 was $4.70M, a 34.29% increase from fiscal 2022.
- Quanterix Corporation depreciation for fiscal 2022 was $3.50M, a 25.00% increase from fiscal 2021.
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $7.00M 10-K · filed 2026-03-02 |
| 2024-12-31 | $4.80M 10-K · filed 2026-03-02 |
| 2023-12-31 | $4.70M 10-K · filed 2026-03-02 |
| 2022-12-31 | $3.50M 10-K · filed 2025-03-17 |
| 2021-12-31 | $2.80M 10-K/A · filed 2024-12-26 |
| 2020-12-31 | $2.20M 10-K · filed 2023-03-06 |
| 2019-12-31 | $1.60M 10-K · filed 2022-03-01 |
| 2018-12-31 | $700.00K 10-K · filed 2020-03-13 |
| 2017-12-31 | $500.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |